Evaluation of melatonin and prostaglandin E1 combination on necrotizing enterocolitis model in neonatal rats

Regulatory Peptides

Volumn 184, Issue , 2013, Pages 121-125

  Çekmez, Ferhat ^a   Çetinkaya, Merih ^a   Tayman, Cüneyt ^a   Canpolat, Fuat Emre ^a   Kafa, Ilker Mustafa ^b   Uysal, Sema ^c   Tunc, Turan ^a   Sarici, S Ümit ^a  

^a Gulhane Military Academy   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

^c FATIH UNIVERSITY   (Turkey)

Author keywords

Melatonin; NEC; Preterm infant; Prostaglandin E1

Indexed keywords

CARBON DIOXIDE; LIPID; MELATONIN; PROSTAGLANDIN E1; PROSTAVASIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBON DIOXIDE BREATHING; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; HEALING; HISTOPATHOLOGY; INTESTINE INJURY; LIPID PEROXIDATION; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM;

ALPROSTADIL; ANIMALS; ANIMALS, NEWBORN; DRUG THERAPY, COMBINATION; ENTEROCOLITIS, NECROTIZING; FEMALE; MELATONIN; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 84877066418     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2013.03.016     Document Type: Article

References (30)

1. Lin P.W., Stoll B.J. Necrotising enterocolitis. Lancet 2006, 368:1271-1283.
2. Ryder R.W., Shelton J.D., Guinan M.E. Necrotizing enterocolitis: a prospective multicenter investigation. Am J Epidemiol 1980, 112:113-123.
3. Fox T.P., Godavitarne C. What really causes necrotising enterocolitis?. ISRN Gastroenterol 2012, 2012:9. 10.5402/2012/628317.
4. Hsueh W., Caplan M.S., Qu X.W., et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003, 6:6-23.
5. Covert R.F., Neu J., Elliott M.J., et al. Factors associated with age of onset of necrotizing enterocolitis. Am J Perinatol 1989, 6:455-460.
6. Reppert S.M., Klein D.C. Transport of maternal[3H]melatonin to suckling rats and the fate of [3H]melatonin in the neonatal rat. Endocrinology Feb. 1978, 102(2):582-588.
7. Konturek S.J., Konturek P.C., Brzozowska I., Pawlik M., Sliwowski Z., Cześnikiewicz-Guzik M., Kwiecień S., Brzozowski T., Bubenik G.A., Pawlik W.W. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J Physiol Pharmacol Sep. 2007, 58(3):381-405. [Review].
8. Smedfors B., Johansson C. Stimulation of duodenal bicarbonate secretion by misoprostol. Dig Dis Sci 1986, 3:S96-S100.
9. Davies N.M., Longstreth J., Jamali F. Misoprostol therapeutics revisited. Pharmacotherapy 2001, 21:60-73.
10. Draper H.H. HadleyM: malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990, 186:421-431.
11. Sun K., Cao S., Pei L., Matsuura A., Xiang L., Qi J. A Steroidal Saponin from Ophiopogon japonicus Extends the Lifespan of Yeast via the Pathway Involved in SOD and UTH1. Int J Mol Sci 2013 Feb 25, 14(3):4461-4475.
12. Valentine W.N., Paglia D.E. Syndromes with increased red cell glutathione (GSH). Hemoglobin 1980, 4(5-6):799-804.
13. Zani A., Cordischi L., Cananzi M., De Coppi P., Smith V.V., Eaton S., Pierro A. Assessment of a neonatal rat model of necrotizing enterocolitis. Eur J Pediatr Surg 2008, 18:423-426.
14. Nadler E.P., Dickinson E., Knisely A., et al. Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis. J Surg Res 2000, 92:71-77.
15. Jilling T., Lu J., Jackson M., et al. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res 2004, 55:622-629.
16. Bandyopadhyay D., Chattopadhyay A. Reactive oxygen species-induced gastric ulceration: protection by melatonin. Curr Med Chem 2006, 13(10):1187-1202. [Review].
17. Kehrer J.P., Smith C.V. Natural antioxidants in human health and disease 1994, 25. Academica Pres, San Diego. B. Frei (Ed.).
18. Sies H. Strategies of antioxidant defense. Eur J Biochem 1993, 215:213-219.
19. Raikhlin N.T., Kvetnoy I.M. Melatonin and enterochromaffin cells. Acta Histochem 1976, 55:19-24.
20. Bubenik G.A., Pang S.F., Cockshut J.R., Smith P.S., Grovum L.W., Friendship R.M., Hacker R.R. Circadian variation of portal, arterial and venous blood levels of melatonin in pigs and its relationship to food intake and sleep. J Pineal Res Jan. 2000, 28(1):9-15.
21. de Souza Pereira R. Regression of gastroesophageal reflux disease symptoms using dietary supplemantation with melatonin, vitamins and amino acids: comparison with omeprazole. J Pineal Res 2006, 41:195-200.
22. Reiter R.J., Tan D.X., Jou M.J., Flores L.J., Reiter R.J. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites. Neuro Endocrinol Lett 2008, 29:391-398.
23. Kesik V., Guven A., Vurucu S., Tunc T., Uysal B., Gundogdu G., Oztas E., Korkmaz A. Melatonin and1400 W ameliorate both intestinal and remote organ injury following mesenteric ischemia/reperfusion. J Surg Res 2009, 157:97-105.
24. Reiter R.J., Tan D.X. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003, 58:10-19.
25. Reiter R.J., Tan D.X., Osuna C., Gitto E. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci 2000, 7:444-458.
26. Graham D.Y., Agrawal N.M., Roth S.H. Prevention of NSAID induced gastric ulcer with misoprostol: multicentre double-blind, placebo controlled trial. Lancet 1988, 2:1277-1280.
27. Topcu I., Vatansever S., Var A., Cavus Z., Cilaker S., Sakarya M. The effect of misoprostol, a prostaglandin E1 analog, on apoptosis in ischemia-reperfusion-induced intestinal injury. Acta Histochem 2007, 109(4):322-329. [Epub 2007 Apr 12].
28. Topsakal C., Kilic N., Ozveren F., Akdemir I., Kaplan M., Tiftikci M., Gursu F. Effects of prostaglandin E1, melatonin, and oxytetracycline on lipid peroxidation, antioxidant defense system, paraoxonase (PON1) activities, and homocysteine levels in an animal model of spinal cord injury. Spine (Phila Pa 1976) Aug. 1 2003, 28(15):1643-1652.
29. Cetinkaya M., Alkan T., Ozyener F., Kafa I.M., Kurt M.A., Koksal N. Possible neuroprotective effects of magnesium sulfate and melatonin as pre- and post-treatment in a neonatal hypoxic-ischemic rat model. Neonatology 2011, 99(4):302-310.
30. Ozyener F., Cetinkaya M., Alkan T., Goren B., Kafa I.M., Kurt M.A., Koksal N. Neuroprotective effects of melatonin administered alone or in combination with topiramate in neonatal hypoxic-ischemic rat model. Restor Neurol Neurosci 2012, 30(5):435-444.